These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 350047)

  • 1. Abnormal alpha cell function in human diabetes: the response to oral protein.
    Raskin P; Aydin I; Yamamoto T; Unger RH
    Am J Med; 1978 Jun; 64(6):988-97. PubMed ID: 350047
    [No Abstract]   [Full Text] [Related]  

  • 2. [A better estimation of beta-langerhans function in diabetes mellitus. The insulin-secretion coefficient].
    Duprey J; Lubetzki J; Azerad E
    Presse Med (1893); 1970 Nov; 78(47):2057-60. PubMed ID: 4921672
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.
    Müller WA; Faloona GR; Aguilar-Parada E; Unger RH
    N Engl J Med; 1970 Jul; 283(3):109-15. PubMed ID: 4912452
    [No Abstract]   [Full Text] [Related]  

  • 4. Glucagon and diabetes mellitus.
    Unger RH
    Adv Metab Disord; 1972; 6():73-98. PubMed ID: 4629970
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-glucagon ratio.
    Unger RH
    Isr J Med Sci; 1972 Mar; 8(3):252-7. PubMed ID: 4557377
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple method for regulating and monitoring circulating glucose levels.
    Costrini NV; Ganeshappa KP; Whalen GE; Soergel KH
    J Lab Clin Med; 1973 Jul; 82(1):179-86. PubMed ID: 4718001
    [No Abstract]   [Full Text] [Related]  

  • 9. C-peptide response to glycaemic stimuli.
    Samal KC; Das S; Parija CR; Tripathy BB
    J Assoc Physicians India; 1987 May; 35(5):362-4. PubMed ID: 3320022
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagon and diabetes mellitus.
    Herlihy B
    Crit Care Nurse; 1983; 3(1):38-43. PubMed ID: 6402337
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal pancreatic alpha-cell function in bacterial infections.
    Rocha DM; Santeusanio F; Faloona GR; Unger RH
    N Engl J Med; 1973 Apr; 288(14):700-3. PubMed ID: 4569497
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus.
    Del Prete GF; Betterle C; Padovan D; Erle G; Toffolo A; Bersahi G
    Diabetes; 1977 Oct; 26(10):909-15. PubMed ID: 332567
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetes.
    Aydin I; Raskin P; Unger RH
    Diabetologia; 1977 Dec; 13(6):629-36. PubMed ID: 590654
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of sulpiride on the endocrine pancreas (author's transl)].
    Suzuki H; Ishikawa M; Kamma N; Hiraiwa M; Kobori H; Shimoda S
    Nihon Naibunpi Gakkai Zasshi; 1981 Dec; 57(12):1707-15. PubMed ID: 7035237
    [No Abstract]   [Full Text] [Related]  

  • 15. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does glucagon play a role in the insulin resistance of patients with adult non-ketotic diabetes?
    Olefsky JM; Sperling MA; Reaven GM
    Diabetologia; 1977 Aug; 13(4):327-30. PubMed ID: 913924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell.
    Kawamori R; Shichiri M; Goriya Y; Yamasaki Y; Shigeta Y; Abe H
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):339-51. PubMed ID: 343466
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
    Otim MA
    East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
    Murayama Y; Kawai K; Watanabe Y; Yoshikawa H; Yamashita K
    J Clin Endocrinol Metab; 1989 May; 68(5):925-31. PubMed ID: 2654170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.
    Block MB; Rosenfield RL; Mako ME; Steiner DF; Rubenstein AH
    N Engl J Med; 1973 May; 288(22):1144-8. PubMed ID: 4633551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.